GlassScriptPhysician profile
Heidi C Rogers
NPI 1447660568
$2,131.22
in general payments reported to CMS, 2019-2025
17 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $472 · 2021: $947 · 2022: $103 · 2023: $33.96 · 2024: $123 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $957.72 | 2019-2025 | |
| Amgen INC. | $259.66 | 2019-2021 | |
| Lilly USA, LLC | $170.28 | 2020-2021 | |
| Janssen Biotech, INC. | $149.33 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $142.27 | 2021-2024 | Saphnelo |
| Horizon Therapeutics Plc | $124.89 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $59.09 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $50.60 | 2020 | |
| Ucb, INC. | $47.19 | 2021 | |
| Genzyme Corporation | $36.50 | 2022-2023 | |
| Glaxosmithkline, LLC. | $24.84 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $21.36 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $21.30 | 2019 | |
| Aurinia Pharma U.S., INC. | $16.62 | 2022 | |
| Mylan Specialty L.P. | $16.61 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.58 | 2023 | Ponvory |
| Oxford Immunotec USA INC | $16.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.